vs
Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $64.3M, roughly 1.2× CAMDEN NATIONAL CORP). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs 7.4%, a 26.6% gap on every dollar of revenue. Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 22.6%).
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
CAC vs VMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $64.3M | $76.2M |
| Net Profit | $21.9M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | — | 11.0% |
| Net Margin | 34.0% | 7.4% |
| Revenue YoY | — | 25.5% |
| Net Profit YoY | — | 30.7% |
| EPS (diluted) | $1.29 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | $76.2M | ||
| Q3 25 | $65.4M | $71.9M | ||
| Q2 25 | $62.3M | $63.1M | ||
| Q1 25 | $60.1M | $59.1M | ||
| Q4 24 | $47.6M | $60.7M | ||
| Q3 24 | $45.0M | $58.0M | ||
| Q2 24 | $42.8M | $55.0M |
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | $5.6M | ||
| Q3 25 | $21.2M | $3.5M | ||
| Q2 25 | $14.1M | $3.2M | ||
| Q1 25 | $7.3M | $2.6M | ||
| Q4 24 | $14.7M | $4.3M | ||
| Q3 24 | $13.1M | $3.9M | ||
| Q2 24 | $12.0M | $1.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% |
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | 11.0% | ||
| Q3 25 | 40.5% | 7.8% | ||
| Q2 25 | 28.5% | 8.1% | ||
| Q1 25 | 10.3% | 6.5% | ||
| Q4 24 | 38.7% | 10.6% | ||
| Q3 24 | 35.2% | 9.7% | ||
| Q2 24 | 34.7% | 6.6% |
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | 7.4% | ||
| Q3 25 | 32.4% | 4.9% | ||
| Q2 25 | 22.6% | 5.0% | ||
| Q1 25 | 12.2% | 4.4% | ||
| Q4 24 | 30.8% | 7.1% | ||
| Q3 24 | 29.1% | 6.7% | ||
| Q2 24 | 28.0% | 2.7% |
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | $0.14 | ||
| Q3 25 | $1.25 | $0.09 | ||
| Q2 25 | $0.83 | $0.08 | ||
| Q1 25 | $0.43 | $0.06 | ||
| Q4 24 | $1.00 | $0.10 | ||
| Q3 24 | $0.90 | $0.10 | ||
| Q2 24 | $0.81 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $13.5M |
| Total DebtLower is stronger | $514.4M | — |
| Stockholders' EquityBook value | $710.0M | $141.5M |
| Total Assets | $7.0B | $199.2M |
| Debt / EquityLower = less leverage | 0.72× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $13.5M | ||
| Q3 25 | — | $11.1M | ||
| Q2 25 | — | $20.0M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | — | $17.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $8.8M |
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | $141.5M | ||
| Q3 25 | $676.4M | $133.6M | ||
| Q2 25 | $652.1M | $139.7M | ||
| Q1 25 | $640.1M | $134.8M | ||
| Q4 24 | $531.2M | $131.4M | ||
| Q3 24 | $529.9M | $125.0M | ||
| Q2 24 | $508.3M | $119.4M |
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | $199.2M | ||
| Q3 25 | $7.0B | $202.4M | ||
| Q2 25 | $6.9B | $184.6M | ||
| Q1 25 | $7.0B | $178.1M | ||
| Q4 24 | $5.8B | $177.1M | ||
| Q3 24 | $5.7B | $169.5M | ||
| Q2 24 | $5.7B | $163.9M |
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | $18.4M | ||
| Q3 25 | $36.1M | $18.4M | ||
| Q2 25 | $6.0M | $12.3M | ||
| Q1 25 | $1.0M | $2.9M | ||
| Q4 24 | $60.9M | $15.0M | ||
| Q3 24 | $-14.5M | $12.7M | ||
| Q2 24 | $14.5M | $10.2M |
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $9.7M | ||
| Q3 25 | $35.4M | $10.7M | ||
| Q2 25 | $4.5M | $4.1M | ||
| Q1 25 | $-727.0K | $-12.6M | ||
| Q4 24 | $55.4M | $3.2M | ||
| Q3 24 | $-16.2M | $1.7M | ||
| Q2 24 | $13.2M | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | 12.7% | ||
| Q3 25 | 54.1% | 14.9% | ||
| Q2 25 | 7.3% | 6.5% | ||
| Q1 25 | -1.2% | -21.4% | ||
| Q4 24 | 116.4% | 5.2% | ||
| Q3 24 | -36.0% | 3.0% | ||
| Q2 24 | 30.8% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | 11.5% | ||
| Q3 25 | 1.1% | 10.6% | ||
| Q2 25 | 2.4% | 12.9% | ||
| Q1 25 | 2.9% | 26.2% | ||
| Q4 24 | 11.7% | 19.5% | ||
| Q3 24 | 3.8% | 19.0% | ||
| Q2 24 | 3.0% | 16.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | 3.27× | ||
| Q3 25 | 1.70× | 5.23× | ||
| Q2 25 | 0.43× | 3.88× | ||
| Q1 25 | 0.14× | 1.09× | ||
| Q4 24 | 4.15× | 3.47× | ||
| Q3 24 | -1.11× | 3.29× | ||
| Q2 24 | 1.21× | 6.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
VMD
Segment breakdown not available.
